Cargando…

SX-ELLA biodegradable stent for benign oesophageal strictures: a systematic review and proportion meta-analysis

BACKGROUND: This systematic review aimed to analyse the use of the SX-ELLA biodegradable stent (BDS) for benign oesophageal strictures through the assessment of clinical and technical success, differences in pre- and post-BDS insertion dysphagia scores, rates of stent migration, and safety. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kailla, Elisha, Rezai, Fatema, Kansci, Ange Kamille, Akande, Oluwadamilola, Gossage, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082093/
https://www.ncbi.nlm.nih.gov/pubmed/36481820
http://dx.doi.org/10.1007/s00464-022-09767-w
_version_ 1785021246620041216
author Kailla, Elisha
Rezai, Fatema
Kansci, Ange Kamille
Akande, Oluwadamilola
Gossage, James
author_facet Kailla, Elisha
Rezai, Fatema
Kansci, Ange Kamille
Akande, Oluwadamilola
Gossage, James
author_sort Kailla, Elisha
collection PubMed
description BACKGROUND: This systematic review aimed to analyse the use of the SX-ELLA biodegradable stent (BDS) for benign oesophageal strictures through the assessment of clinical and technical success, differences in pre- and post-BDS insertion dysphagia scores, rates of stent migration, and safety. METHODS: A systematic review was reported according to PRISMA guidelines, with a prospectively registered protocol. The databases PubMed, Embase, SCOPUS, and ClinicalTrials.gov were searched up to March 2022. Studies assessing the use of the SX-ELLA BDS in adults with benign oesophageal strictures were included. A pooled data analysis was conducted to analyse the clinical and technical success associated with BDS use, rate of stent migration, and safety. RESULTS: Of the 1509 articles identified, 16 studies treating 246 patients were eligible for inclusion. BDS was clinically successful in 41.9% of cases (95% CI = 35.7 – 48.1%), defined as those who experienced complete symptom resolution following BDS insertion. Technical success was achieved in 97.2% of patients (95% CI = 95.1 – 99.3%). A pooled analysis concluded a decrease in mean dysphagia score of 1.8 points (95% CI = 1.68 – 1.91) following BDS insertion. Re-intervention was required in 89 patients (36.2%, 95% CI = 30.2 – 42.2%), whilst stent migration occurred in 6.5% of patients (95% CI = 3.4 – 9.6%). A total of 37 major clinical complications related to BDS insertion were reported (15.0%, 95% CI = 10.5 – 19.5%). CONCLUSION: The pooled data analysis demonstrates the high technical and moderate clinical success of the SX-ELLA biodegradable stent, supporting its use for benign oesophageal strictures in adults. However, greater evidence is required for more robust conclusions to be made in terms of success when compared to alternative methods of intervention, such as endoscopic dilation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-022-09767-w.
format Online
Article
Text
id pubmed-10082093
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100820932023-04-09 SX-ELLA biodegradable stent for benign oesophageal strictures: a systematic review and proportion meta-analysis Kailla, Elisha Rezai, Fatema Kansci, Ange Kamille Akande, Oluwadamilola Gossage, James Surg Endosc Review Article BACKGROUND: This systematic review aimed to analyse the use of the SX-ELLA biodegradable stent (BDS) for benign oesophageal strictures through the assessment of clinical and technical success, differences in pre- and post-BDS insertion dysphagia scores, rates of stent migration, and safety. METHODS: A systematic review was reported according to PRISMA guidelines, with a prospectively registered protocol. The databases PubMed, Embase, SCOPUS, and ClinicalTrials.gov were searched up to March 2022. Studies assessing the use of the SX-ELLA BDS in adults with benign oesophageal strictures were included. A pooled data analysis was conducted to analyse the clinical and technical success associated with BDS use, rate of stent migration, and safety. RESULTS: Of the 1509 articles identified, 16 studies treating 246 patients were eligible for inclusion. BDS was clinically successful in 41.9% of cases (95% CI = 35.7 – 48.1%), defined as those who experienced complete symptom resolution following BDS insertion. Technical success was achieved in 97.2% of patients (95% CI = 95.1 – 99.3%). A pooled analysis concluded a decrease in mean dysphagia score of 1.8 points (95% CI = 1.68 – 1.91) following BDS insertion. Re-intervention was required in 89 patients (36.2%, 95% CI = 30.2 – 42.2%), whilst stent migration occurred in 6.5% of patients (95% CI = 3.4 – 9.6%). A total of 37 major clinical complications related to BDS insertion were reported (15.0%, 95% CI = 10.5 – 19.5%). CONCLUSION: The pooled data analysis demonstrates the high technical and moderate clinical success of the SX-ELLA biodegradable stent, supporting its use for benign oesophageal strictures in adults. However, greater evidence is required for more robust conclusions to be made in terms of success when compared to alternative methods of intervention, such as endoscopic dilation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-022-09767-w. Springer US 2022-12-08 2023 /pmc/articles/PMC10082093/ /pubmed/36481820 http://dx.doi.org/10.1007/s00464-022-09767-w Text en © Crown 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Kailla, Elisha
Rezai, Fatema
Kansci, Ange Kamille
Akande, Oluwadamilola
Gossage, James
SX-ELLA biodegradable stent for benign oesophageal strictures: a systematic review and proportion meta-analysis
title SX-ELLA biodegradable stent for benign oesophageal strictures: a systematic review and proportion meta-analysis
title_full SX-ELLA biodegradable stent for benign oesophageal strictures: a systematic review and proportion meta-analysis
title_fullStr SX-ELLA biodegradable stent for benign oesophageal strictures: a systematic review and proportion meta-analysis
title_full_unstemmed SX-ELLA biodegradable stent for benign oesophageal strictures: a systematic review and proportion meta-analysis
title_short SX-ELLA biodegradable stent for benign oesophageal strictures: a systematic review and proportion meta-analysis
title_sort sx-ella biodegradable stent for benign oesophageal strictures: a systematic review and proportion meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082093/
https://www.ncbi.nlm.nih.gov/pubmed/36481820
http://dx.doi.org/10.1007/s00464-022-09767-w
work_keys_str_mv AT kaillaelisha sxellabiodegradablestentforbenignoesophagealstricturesasystematicreviewandproportionmetaanalysis
AT rezaifatema sxellabiodegradablestentforbenignoesophagealstricturesasystematicreviewandproportionmetaanalysis
AT kansciangekamille sxellabiodegradablestentforbenignoesophagealstricturesasystematicreviewandproportionmetaanalysis
AT akandeoluwadamilola sxellabiodegradablestentforbenignoesophagealstricturesasystematicreviewandproportionmetaanalysis
AT gossagejames sxellabiodegradablestentforbenignoesophagealstricturesasystematicreviewandproportionmetaanalysis